LOGOS GLOBAL MASTER FUND LP purchased 650.0% of their position (476.67K shares) of VIRIDIAN THERAPEUTICS, INC.\DE on the open market
Open‑market purchase worth $2.27M — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 11/16/2020ACC: 0001567619-20-019923
10% Owner
Since Nov 2020
+476.67K
Net shares
Net buyer
$2.27M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
476.67K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+250K
Price / share
$1.10
Trade value
$274.48K
% of position
4.2%
11/9/2020
6M→6.25M
Common Stock
Direct
Shares
+100K
Price / share
$1.16
Trade value
$116.41K
% of position
1.6%
11/9/2020
6.25M→6.35M
Common Stock
Direct
Shares
+126.67K
Price / share
$14.84
Trade value
$1.88M
% of position
29.9%
11/13/2020
423.33K→550K
Total
Net shares
+476.67K
Net value
$2.27M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/9/2020 | P · Purchase | +250K | $1.10 | $274.48K | 4.2% | 6M | 6.25M |
| Common Stock Direct | 11/9/2020 | P · Purchase | +100K | $1.16 | $116.41K | 1.6% | 6.25M | 6.35M |
| Common Stock Direct | 11/13/2020 | P · Purchase | +126.67K | $14.84 | $1.88M | 29.9% | 423.33K | 550K |
| Total | +476.67K | $2.27M | ||||||
Derivative Transactions0
No derivative transactions reported